8-K
filed May 28, 2026, 4:01 PM ET
ticker RPRX
CIK 0001802768
debt
confidence high
sentiment neutral
materiality 0.50
Royalty Pharma enters new $1.8B unsecured revolver maturing 2031
Royalty Pharma plc
- New $1.8B unsecured revolving credit facility replaces existing agreement from 2021.
- Matures May 22, 2031; interest rate based on SOFR or base rate plus margin per pricing grid.
- Covenants: leverage ratio ≤4.00x (4.50x post-acquisition), portfolio cash flow ≤5.00x (5.50x), coverage ≥2.50x.
- Borrower: Royalty Pharma Holdings Ltd; guarantors: Royalty Pharma plc and Royalty Pharma Manager, LLC.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-26-245163
- form_type
- 8-K
- ticker
- RPRX
- cik
- 0001802768
- company_name
- Royalty Pharma plc
- filed_at
- 2026-05-28T20:01:40+00:00
- discovered_at
- 2026-05-28T20:03:31.526493+00:00
- generated_at
- 2026-05-28T21:26:13.579112+00:00
- sec_items
- ["1.01", "2.03", "9.01"]
- event_type
- debt
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-26-245163
- json_url
- https://secwatch.observer/filing/0001193125-26-245163.json
- markdown_url
- https://secwatch.observer/filing/0001193125-26-245163.md
- text_url
- https://secwatch.observer/filing/0001193125-26-245163.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1802768/000119312526245163/0001193125-26-245163-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1802768/000119312526245163/d131735d8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
BFAM
Bright Horizons secures $375M term loan, ups revolver to $1B with 2030 maturity
BRIGHT HORIZONS FAMILY SOLUTIONS INC.
June 1, 2026, 4:31 PM ET
debt
Items 1.01, 2.03, 9.01
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
Filing page
SEC filing
EHC
Encompass Health issues $500M 5.875% notes due 2034; to redeem $400M of 4.500% notes due 2028
Encompass Health Corp
June 1, 2026, 4:26 PM ET
debt
Items 1.01, 2.03, 9.01
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
Filing page
SEC filing
PFG
Principal Financial Group issues $400M of 5.300% Senior Notes due 2037
PRINCIPAL FINANCIAL GROUP INC
June 1, 2026, 4:05 PM ET
debt
Items 1.01, 2.03, 8.01, 9.01
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
Filing page
SEC filing
NE
Noble boosts revolver to $650M, extends to 2031; plans $500M notes due 2034 to refinance 8.5% Diamond Notes
Noble Corp plc
June 1, 2026, 8:04 AM ET
debt
Items 1.01, 2.03, 8.01, 9.01
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
Filing page
SEC filing
XPO
XPO Inc. enters $385M Term Loan B and $500M Term Loan A to refinance existing debt
XPO, Inc.
June 1, 2026, 6:48 AM ET
debt
Items 1.01, 2.03, 9.01
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
Filing page
SEC filing
AYR
Aircastle enters $375M unsecured term loan facility with option to increase to $425M
Aircastle LTD
May 29, 2026, 8:57 PM ET
debt
Items 1.01, 2.03, 9.01
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
Filing page
SEC filing
AAL
American Airlines refinances $1.15B term loans and adds $703M incremental term loans due 2033
American Airlines Group Inc.
May 29, 2026, 5:24 PM ET
debt
Items 1.01, 2.03, 9.01
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
Filing page
SEC filing
KW
Kennedy-Wilson issues $1.8B in senior notes at 7.000% and 7.250% for refinancing ahead of going-private merger
Kennedy-Wilson Holdings, Inc.
May 29, 2026, 4:54 PM ET
debt
Items 1.01, 2.03, 9.01
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.